Related Experiment Video
Updated: Mar 16, 2026

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
The estrogen-related receptors (ERRs): potential targets against bone loss
Ling Zhang1,2, Jiemin Wong2, Jean-Marc Vanacker3
1Institut de Génomique Fonctionnelle de Lyon, CNRS UMR5242, Université de Lyon, Université Lyon I, Ecole Normale Supérieure de Lyon, Lyon, France.
Abstract:
Bone loss and the resulting skeletal fragility is induced by several pathological or natural conditions, the most prominent of which being aging as well as the decreased levels of circulating estrogens in post-menopause females. To date, most treatments against bone loss aim at preventing excess bone resorption. We here summarize data indicating that the estrogen-related receptors (ERRs) α and γ prevent bone formation. Inhibiting these receptors may thus constitute an anabolic approach by increasing bone formation.
Insights
Estrogen-related receptors (ERRs) alpha and gamma hinder bone formation. Inhibiting these receptors offers a new anabolic strategy to combat bone loss and skeletal fragility, particularly in post-menopause women.
Area of Science:
- Endocrinology
- Bone Biology
- Metabolic Diseases
Background:
- Bone loss and skeletal fragility are significant health issues, often linked to aging and estrogen deficiency in post-menopausal women.
- Current treatments primarily focus on inhibiting bone resorption, leaving a need for anabolic strategies that promote bone formation.
Purpose of the Study:
- To investigate the role of estrogen-related receptors (ERRs) alpha and gamma in bone formation.
- To explore the potential of inhibiting ERRs as an anabolic therapeutic approach for bone loss.
Main Methods:
- Review and summarization of existing data on estrogen-related receptors (ERRs) alpha and gamma.
- Analysis of the impact of ERRs on bone formation processes.
Main Results:
- Data indicate that estrogen-related receptors (ERRs) alpha and gamma actively prevent bone formation.
- This suggests a novel mechanism by which these receptors influence skeletal health.
Conclusions:
- Inhibition of estrogen-related receptors (ERRs) alpha and gamma presents a promising anabolic strategy to increase bone formation.
- Targeting ERRs could offer a new therapeutic avenue for treating bone loss and preventing skeletal fragility.
Related Concept Videos
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

